GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Casp9 | decreases expression | EXP | | 6480464 | CTD | Streptozocin results in decreased expression of CASP9 protein | PMID:34455488 | Casp9 | increases activity | EXP | | 6480464 | CTD | Streptozocin results in increased activity of CASP9 protein | PMID:22940631 PMID:29606028 | Casp9 | increases expression | EXP | | 6480464 | CTD | Streptozocin results in increased expression of CASP9 mRNA; Streptozocin results in increased expression of CASP9 protein | PMID:19951573 PMID:26614261 PMID:28856781 PMID:36462176 | Casp9 | multiple interactions | EXP | | 6480464 | CTD | Anthocyanins inhibits the reaction [Streptozocin results in increased expression of CASP9 protein]; IGF2R protein modified form inhibits the reaction [Streptozocin results in increased expression of CASP9 protein]; Insulin promotes the reaction [Ozone inhibits the reaction [Streptozocin results in increased expression of CASP9 mRNA]]; nifuroxazide inhibits the reaction [Streptozocin results in increased activity of CASP9 protein]; Ozone inhibits the reaction [Streptozocin results in increased expression of CASP9 mRNA]; Phosphocreatine inhibits the reaction [Streptozocin results in decreased expression of CASP9 protein]; Streptozocin results in increased expression of and results in increased cleavage of CASP9 protein; Thioctic Acid inhibits the reaction [Streptozocin results in increased expression of CASP9 protein] | PMID:15976052 PMID:19951573 PMID:26614261 PMID:28856781 PMID:29606028 PMID:34455488 PMID:36462176 | |
Go Back to source page | Continue to Ontology report |